NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer

CONCLUSION: NECTIN4 amplifications are genomic predictors of EV responses and long-term survival in patients with mUC.PMID:38657187 | DOI:10.1200/JCO.23.01983

Source: Clinical Breast Cancer - April 24, 2024 Category: Cancer & Oncology Authors: Niklas Kl ümper Ngoc Khanh Tran Stefanie Zsch äbitz Oliver Hahn Thomas B üttner Florian Roghmann Christian Bolenz Friedemann Zengerling Constantin Schwab Dora Nagy Marieta Toma Glen Kristiansen Hendrik Heers Philipp Ivanyi G ünter Niegisch Camilla Mar Source Type: research